| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
Asset Impairment Charge | 506721000.0 | 0.0 | 0.0 | | |
Beginning Cash Position | | 990166000.0 | 714701000.0 | 653463000.0 | 1102007000.0 |
Capital Expenditure | | -266136000.0 | -339632000.0 | -512675000.0 | -567339000.0 |
Cash Dividends Paid | | -465649000.0 | -495917000.0 | -526674000.0 | -554931000.0 |
Cash Flow From Continuing Financing Activities | | -989532000.0 | 205101000.0 | -292161000.0 | -333936000.0 |
Cash Flow From Continuing Investing Activities | | -506164000.0 | -1684240000.0 | -705792000.0 | -1507524000.0 |
Cash Flow From Continuing Operating Activities | | 1258285000.0 | 1466971000.0 | 1435610000.0 | 1251251000.0 |
Cash From Discontinued Financing Activities | 0.0 | 0.0 | 0.0 | | |
Cash From Discontinued Investing Activities | -11131000.0 | 0.0 | 0.0 | | |
Cash From Discontinued Operating Activities | 5039000.0 | 0.0 | 0.0 | | |
Change In Account Payable | | 777318000.0 | 676406000.0 | 2038000.0 | 512347000.0 |
Change In Inventory | | -329237000.0 | -380420000.0 | -69148000.0 | -440549000.0 |
Change In Other Current Assets | | | 350528000.0 | 175838000.0 | 511584000.0 |
Change In Other Current Liabilities | | | -421544000.0 | -429874000.0 | -619765000.0 |
Change In Other Working Capital | -51909000.0 | -200411000.0 | -71016000.0 | -254036000.0 | |
Change In Payable | | 777318000.0 | 676406000.0 | 2038000.0 | 512347000.0 |
Change In Payables And Accrued Expense | | 777318000.0 | 676406000.0 | 2038000.0 | 512347000.0 |
Change In Receivables | | -258994000.0 | -244371000.0 | 31989000.0 | -50939000.0 |
Change In Working Capital | | -11324000.0 | -19401000.0 | -289157000.0 | -87322000.0 |
Changes In Account Receivables | | -258994000.0 | -244371000.0 | 31989000.0 | -50939000.0 |
Changes In Cash | | -237411000.0 | -12168000.0 | 437657000.0 | -590209000.0 |
Common Stock Dividend Paid | | -465649000.0 | -495917000.0 | -526674000.0 | -554931000.0 |
Common Stock Payments | | -333599000.0 | -222726000.0 | -261473000.0 | -149999000.0 |
Deferred Income Tax | | 31676000.0 | 2220000.0 | 42114000.0 | -18598000.0 |
Deferred Tax | | 31676000.0 | 2220000.0 | 42114000.0 | -18598000.0 |
Depreciation Amortization Depletion | | 290971000.0 | 347819000.0 | 350529000.0 | 407978000.0 |
Depreciation And Amortization | | 290971000.0 | 347819000.0 | 350529000.0 | 407978000.0 |
Earnings Losses From Equity Investments | 0.0 | -10229000.0 | | | |
Effect Of Exchange Rate Changes | | -38054000.0 | -49070000.0 | 10887000.0 | -31807000.0 |
End Cash Position | | 714701000.0 | 653463000.0 | 1102007000.0 | 479991000.0 |
Excess Tax Benefit From Stock Based Compensation | -677000.0 | -7076000.0 | | | |
Financing Cash Flow | | -989532000.0 | 205101000.0 | -292161000.0 | -333936000.0 |
Free Cash Flow | | 992149000.0 | 1127339000.0 | 922935000.0 | 683912000.0 |
Gain Loss On Investment Securities | | | -102803000.0 | | -43049000.0 |
Gain Loss On Sale Of PPE | 0.0 | 61063000.0 | | | |
Income Tax Paid Supplemental Data | | 305326000.0 | 362859000.0 | 366270000.0 | 264625000.0 |
Interest Paid Supplemental Data | | 65732000.0 | 73368000.0 | 90405000.0 | 124977000.0 |
Investing Cash Flow | | -506164000.0 | -1684240000.0 | -705792000.0 | -1507524000.0 |
Issuance Of Debt | | 892694000.0 | 5108641000.0 | 3769132000.0 | 895299000.0 |
Long Term Debt Issuance | | 892694000.0 | 5108641000.0 | 3769132000.0 | 895299000.0 |
Long Term Debt Payments | | -1053423000.0 | -4147773000.0 | -3237959000.0 | -496156000.0 |
Net Business Purchase And Sale | | -266577000.0 | -1656604000.0 | -296127000.0 | -1078607000.0 |
Net Common Stock Issuance | | -333599000.0 | -222726000.0 | -261473000.0 | -149999000.0 |
Net Foreign Currency Exchange Gain Loss | 11356000.0 | 0.0 | | | |
Net Income From Continuing Operations | | 898790000.0 | 1182701000.0 | 1316524000.0 | 904076000.0 |
Net Investment Purchase And Sale | | 0.0 | 158441000.0 | 80482000.0 | 15990000.0 |
Net Issuance Payments Of Debt | | -160729000.0 | 960868000.0 | 531173000.0 | 399143000.0 |
Net Long Term Debt Issuance | | -160729000.0 | 960868000.0 | 531173000.0 | 399143000.0 |
Net Other Financing Charges | | -7209000.0 | -19747000.0 | -11042000.0 | -11261000.0 |
Net Other Investing Changes | | | 8548000.0 | -2571000.0 | |
Net PPEPurchase And Sale | | -239587000.0 | -194625000.0 | -487576000.0 | -444907000.0 |
Operating Cash Flow | | 1258285000.0 | 1466971000.0 | 1435610000.0 | 1251251000.0 |
Operating Gains Losses | 11356000.0 | 50834000.0 | -102803000.0 | | -43049000.0 |
Other Non Cash Items | | 22575000.0 | 18377000.0 | -41626000.0 | 47473000.0 |
Proceeds From Stock Option Exercised | | -22346000.0 | -17377000.0 | -24145000.0 | -16888000.0 |
Purchase Of Business | | -284315000.0 | -1690208000.0 | -306881000.0 | -1080238000.0 |
Purchase Of PPE | | -266136000.0 | -339632000.0 | -512675000.0 | -567339000.0 |
Repayment Of Debt | | -1053423000.0 | -4147773000.0 | -3237959000.0 | -496156000.0 |
Repurchase Of Capital Stock | | -333599000.0 | -222726000.0 | -261473000.0 | -149999000.0 |
Sale Of Business | | 17738000.0 | 33604000.0 | 10754000.0 | 1631000.0 |
Sale Of Investment | | 0.0 | 158441000.0 | 80482000.0 | 15990000.0 |
Sale Of PPE | | 26549000.0 | 145007000.0 | 25099000.0 | 122432000.0 |
Stock Based Compensation | | 25597000.0 | 38058000.0 | 57226000.0 | 40693000.0 |